TRPV1 and diabetic neuropathy: Another study by (Fajrin et al., 2020b) determined the potential activity of 6-paradol and its derivatives to Transient Receptor potential Vanilloid 1 (TRPV1), a target receptor in Painful Diabetic Neuropathy (PDN).